Minnesota 2023-2024 Regular Session

Minnesota Senate Bill SF1029

Introduced
2/1/23  
Refer
2/1/23  
Refer
3/6/23  

Caption

Unrestricted access requirement to services for diagnosis. monitoring, and treatment of rare diseases

Impact

The bill has significant implications for state laws governing health insurance and patient rights. By amending Minnesota Statutes, it requires health plans to provide equal coverage for services associated with rare diseases, irrespective of the provider's network status. This is expected to improve health outcomes for patients who might not have access to specialized care within their health plan's network, thereby enhancing their quality of life.

Summary

SF1029 aims to ensure unrestricted access to services for the diagnosis, monitoring, and treatment of rare diseases in Minnesota. This bill establishes that health plan companies cannot restrict enrollees on where to receive these essential services, which may include consultations with licensed healthcare providers related to rare diseases. The bill specifically defines rare diseases as conditions that affect fewer than 200,000 people in the U.S. or are classified as such by relevant health authorities, ensuring comprehensive coverage for affected individuals.

Contention

While SF1029 has the potential to greatly benefit patients with rare diseases, it may also raise concerns among healthcare providers and insurers regarding the financial impacts of providing services without network restrictions. There could be debate over the adequacy of compensation for out-of-network providers and the overall costs to insurance companies, given that these services may incur higher fees compared to in-network alternatives. Stakeholders may assess how this bill alters the balance of healthcare costs between providers, insurers, and patients.

Companion Bills

MN HF384

Similar To Unrestricted access to services required for diagnosis, monitoring, and treatment of rare diseases.

Previously Filed As

MN HF384

Unrestricted access to services required for diagnosis, monitoring, and treatment of rare diseases.

MN SB461

Providing for patient access to diagnostics and treatments for Lyme disease and related tick-borne illnesses; and requiring health care policies to provide certain coverage.

MN SB100

Providing for patient access to diagnostics and treatments for Lyme disease and related tick-borne illnesses; and requiring health care policies to provide certain coverage.

MN SF1692

Policies governing access to substance use disorder treatment services modification

MN SF1961

Infertility treatment and standard fertility preservation services coverage by health plans requirement, MinnesotaCare and medical assistance coverage of infertility treatment and standard fertility preservation services requirement, and appropriation

MN HB589

Social services; coverage for fertility diagnostic care, treatment, and preservation services; provide

MN SF2449

Mental health provider staffing, documentation and diagnostic assessment requirements modification

MN HF2553

Mental health provider staffing, documentation, and diagnostic assessment requirements modified; certification process required; assertive community treatment and behavioral health home services staff requirements modified; adult rehabilitative mental health services provider entity standards modified; managed care contract requirements modified; grant data and reporting requirements modified; and family peer support services eligibility modified.

MN AB898

Early and Periodic Screening, Diagnostic, and Treatment services: behavioral health.

MN HF1627

Access to substance use disorder treatment services governing policies modified, home and community-based services workforce development grants eligibility modified, and workforce development grant money excluded from income.

Similar Bills

NJ S4018

Requires health insurance and Medicaid coverage for screening, prevention, and treatment services of behavioral health issues affecting children.

NJ A5052

Requires health insurance and Medicaid coverage for screening, prevention, and treatment services of behavioral health issues affecting children.

CA SB706

Public health: pulmonary hypertension task force.

CA AB1955

Alzheimer’s disease and dementia: public awareness campaign.

CA AB1684

Alzheimer’s disease: public awareness campaign.

CA SB987

California Cancer Care Equity Act.

CA AB2418

Perinatal hospice.

CA SB162

Pulmonary hypertension task force.